Wyden Statement on Massachusetts AG Letter to Gilead
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released to following statement regarding a letter sent to Gilead Sciences Inc. by Massachusetts Attorney General Maura Healey: “I commend the Massachusetts Attorney General for challenging Gilead’s decision to put profits before the well-being of people with hepatitis C across the nation. The investigation that […]
Wyden, Grassley Request Comment on Sovaldi Report
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and senior committee member Chuck Grassley, R-Iowa, today sent a letter to the health care and patient community requesting responses to the policy questions raised in their report, “The Price of Sovaldi and Its Impact on the U.S. Health Care System,” released on December 1, 2015. […]
Wyden Statement at Finance Committee Hearing to Discuss Health Care CO-OPs
When Congress wrote the Affordable Care Act, it gave Americans shopping for insurance the option of getting coverage from new, private, non-profits called Consumer Oriented and Operated Plans, or CO-OPs. More than a million people turned to CO-OPs for insurance in 2015 – including many deeply vulnerable people who needed access to top-notch care. That […]
Oregon, Washington Senators Call on USDA to Stand Up for GMO-Free Alfalfa Farmers Exporting To China
Washington, D.C. – Today Oregon Senators Ron Wyden and Jeff Merkley and Washington Senators Patty Murray and Maria Cantwell urged U.S. Agriculture Secretary Tom Vilsack to address China’s restrictions on imports of GMO-free alfalfa hay. More than 1.2 million tons of GMO-free alfalfa is shipped out of western ports annually, and China has been a […]
Wyden Response to GAO Report Highlighting Deteriorating Taxpayer Support from IRS
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., issued a statement today in response to a new GAO report detailing how Internal Revenue Service (IRS) taxpayer services are deteriorating over prior years, coinciding with a 10 percent reduction in IRS annual appropriations and new resource allocation demands to meet changing statutory responsibilities. “Honest taxpayers […]
Wyden Responds to Reports of Companies Shutting Down Offshore Reinsurance Operations
WASHINGTON – Senate Finance Committee Chairman Ron Wyden, D-Ore., today issued the following statement: ”Sophisticated business tax avoidance strategies hurt our country. Our efforts to close this loophole are paying off.” Senator Wyden took numerous steps last year to shut down this tax loophole by calling upon the administration for action and introducing The Offshore Reinsurance Tax […]
Wyden Response to the State of the Union Address
WASHINGTON, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after the president’s State of the Union address: “My hope is that Congress uses this moment of reflection to renew our commitment to creating opportunity for all, while protecting and upholding American values. “Congress must to do more to […]
Hatch, Wyden, Isakson, Warner Release Chronic Care Options Paper
WASHINGTON – Senate Finance Committee Chairman Orrin Hatch, R-Utah, Ranking Member Ron Wyden, D-Ore., along with Senators Johnny Isakson, R-Ga., and Mark Warner, D-Va., co-chairs of the Finance Committee Chronic Care Working Group, today released an options paper outlining policies being considered as a part of the committee’s effort to improve how Medicare treats beneficiaries with multiple, […]
Data Behind the Sovaldi Report: Wyden-Grassley Investigation Looks at Drug Costs in Every State Medicaid Program
As Part of a Comprehensive, Bipartisan Report on the High Cost of Hep C Drugs, Senior Finance Members Collected Data on Drug Cost, Prescription Volume, and Patients Treated in All 50 States, D.C. State Medicaid Programs Imposed Access Restrictions Due to Budget Constraints, Yet Sovaldi Still Dominated Drug Spending WASHINGTON –An investigation released earlier this […]
Wyden Statement on 1332 Waiver Rule from HHS
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following the release of a rule by the Department of Health and Human Services (HHS) regarding Section 1332 of the Affordable Care Act, also known as the State Innovation Waiver: “Today HHS has taken an important step to support states that want […]